Stay updated on NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial
Sign up to get notified when there's something new on the NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial page.

Latest updates to the NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial page
- ChecktodayChange DetectedThe page no longer lists the primary condition 'Schizophrenia' and related topics/MedlinePlus Genetics.SummaryDifference0.2%

- Check7 days agoChange DetectedAdded Schizophrenia topic and MedlinePlus Genetics related topics, and updated the page revision from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check15 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. The related topics 'Schizophrenia' and 'MedlinePlus Genetics' were removed.SummaryDifference0.2%

- Check22 days agoChange DetectedAdded related topic links for Schizophrenia and MedlinePlus Genetics on the page. This is a minor metadata enhancement that does not change core study details or functionality.SummaryDifference0.2%

- Check36 days agoChange DetectedRemoved the primary condition label 'Schizophrenia' and related topics including 'MedlinePlus Genetics' from the page.SummaryDifference0.2%

- Check43 days agoChange DetectedAdded Revision: v3.4.2; removed the lapse-in-government-funding notice and the prior Revision: v3.4.1 from the page.SummaryDifference0.4%

Stay in the know with updates to NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NBI-1117568 in Schizophrenia: Efficacy, Safety & PK Clinical Trial page.